KisoJi Board of Directors

KisoJi benefits from the guidance of a board of directors with extensive experience in building successful companies.

Daniel Hétu, M.D., M.B.A.

Board Director

Dr. Hétu has over 20 years of investment banking, corporate development, and licensing and investment experience.  He has been involved with life sciences companies at all stages of development in North America and overseas. With demonstrated success managing complex initiatives, projects and transactions, Dr. Hétu is recognized for his strategic thinking and problem-solving skills.

Read more

Maxime Pesant, CPA, CMA, CFA

Board Director

Maxime Pesant is Investment Manager for the life science group at the Fonds de Solidarité FTQ. He is involved in several preclinical and clinical-stage life science companies as well as in many venture capital funds.

Read more

Takaaki Tobaru, M.Sc., M.B.A.

Board Director

Mr. Tobaru is a Partner at Remiges Ventures and has more than 20 years of experience in search and evaluation, business development and venture investment. Prior to joining Remiges, he was at Ora as Vice President of Corporate Development with focusing on identifying innovative opportunities for licensing, Joint Venture and new corporate formation.

Read more

Brian J. Underdown, Ph.D.

Board Director

Dr. Underdown brings over 30 years of investment, academic leadership and operational experience in the biopharmaceutical sector. He has been directly involved in the growth of over a dozen successful North American life sciences companies. Dr. Underdown worked at Lumira Capital as Managing Director and Venture Partner from 1997 to 2016.

Read more

David S. Young, M.D.

Board Director and C.E.O.

Dr. Young is the C.E.O. , C.S.O., and co-founder of KisoJi. Previously, he was the founder, C.S.O. and C.E.O. of ARIUS Research Inc., a publicly-traded biotechnology company developing therapeutic cancer antibodies and sold to Roche in 2008. ARIUS had secured partnerships with leading companies such as Genentech, Takeda Pharmaceuticals, and Protein Design Labs.

Read more

Want to know more about us?